Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 54, Issue 2, 2002, Pages 527-535

  Stewart, Kimberly D ^a   Martinez, Alvaro A ^a   Weiner, Sheldon ^a   Podratz, Karl ^b   Stromberg, Jannifer S ^a   Schray, Mark ^b   Mitchell, Christina ^a   Sherman, Alfred ^a   Chen, Peter ^a   Brabbins, Donald A ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Adjuvant radiation; Clear cell; Endometrial cancer; High risk; Serous papillary

Indexed keywords

BIOLOGICAL ORGANS; CELLS; CYTOLOGY; DISEASES; ENZYMES; HISTOLOGY; REGRESSION ANALYSIS; TUMORS; X RAYS;

PROGNOSTIC FACTORS;

ONCOLOGY;

LIVER ENZYME;

ABDOMEN; ADENOCARCINOMA; AGE; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; COMORBIDITY; CONTROLLED STUDY; CYTOLOGY; ENDOMETRIUM CARCINOMA; ENZYME ASSAY; FEMALE; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HISTOLOGY; HUMAN; IRRADIATION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; MYOMETRIUM; PELVIS; PERITONEUM; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RELAPSE; RISK FACTOR; SCAR FORMATION; SURVIVAL RATE; THORAX RADIOGRAPHY; TIME; TREATMENT FAILURE; TREATMENT OUTCOME;

ACTUARIAL ANALYSIS; ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CYSTADENOCARCINOMA, PAPILLARY; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOTHERAPY; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TREATMENT FAILURE;

EID: 0036803145     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02947-4     Document Type: Article

References (49)

1. Journal of American Cancer Society . Cancer statistics. CA-A Cancer J Clin. 49:1999;913.
2. Morrow C.P., Bundy B.N., Kurman R.J., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium A Gynecology Oncology Group study . Gynecol Oncol. 40:1991;55-65.
3. Carey M.S., O'Connell G.J., Johanson C.R., et al. Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol. 57:1995;138-144.
4. Aalders I., Abeler V., Kolstad P., et al. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma. Obstet Gynecol. 56:1980;419-427.
5. Elliott P., Green D., Coates A., et al. The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence and endometrial cancer. Int J Gynecol Cancer. 4:1994;84-90.
6. Kucera H., Vavra N., Weghaupt K. Benefit of external irradiation in pathologic stage I endometrial carcinoma A prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors . Gynecol Oncol. 38:1990;99-104.
7. Randall M., Wilder J., Greven K., et al. Role of intracavitary cuff boost after adjuvant external irradiation in early endometrial carcinoma. Int J Radiat Oncol Biol Phys. 19:1990;49-54.
8. Greven K., Randall M., Fanning J., et al. Patterns of failure in patients with stage I, grade 3 carcinoma of the endometrium. Int J Radiat Oncol Biol Phys. 19:1990;429-435.
9. Mayr N., Wen B., Benda J.A., et al. Postoperative radiation therapy in clinical stage I endometrial cancer Corpus, cervical, and lower uterine segment involvement - Patterns of failure . Radiology. 196:1995;323-328.
10. Laciano R., Curran W., Greven K., et al. Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium. Gynecol Oncol. 40:1991;368-373.
11. Calais G., Vitu L., Descamps P., et al. Preoperative or postoperative brachytherapy for patients with endometrial carcinoma stage I and II. Int J Radiat Oncol Biol Phys. 19:1990;523-527.
12. Grigsby P.W., Perez C.A., Camel H.M., et al. Stage II carcinoma of the endometrium Results of therapy and prognostic factors . Int J Radiat Oncol Biol Phys. 11:1985;1915-1923.
13. Greven K.M., Lanciano R.M., Corn B., et al. Pathologic stage III endometrial carcinoma. Cancer. 71:1993;3697-3702.
14. MacKillop W.J., Pringle J.F. Stage III endometrial carcinoma A review of 90 cases . Cancer. 56:1985;2519-2523.
15. Grigsby P.W., Perez C.A., Kuske R.R., et al. Results of therapy, analysis of failures, and prognostic factors for clinical and pathologic stage III adenocarcinoma of the endometrium. Gynecol Oncol. 27:1987;44-57.
16. Bedwinek J., Galakatos A., Camel M., et al. Stage I, grade 3 adenocarcinoma of the endometrium treated with surgery and irradiation. Cancer. 54:1984;40-47.
17. Eifel P.J., Ross J., Hendrickson M., et al. Adenocarcinoma of the endometrium - Analysis of 256 cases with disease limited to the uterine corpus Treatment comparisons . Cancer. 52:1983;1026-1031.
18. Genest P., Drouin P., Girard A., et al. Stage III carcinoma of the endometrium A review of 41 cases . Gynecol Oncol. 26:1987;77-86.
19. Hendrickson M., Ross J., Eifel P., et al. Uterine papillary serous carcinoma A highly malignant form of endometrial adenocarcinoma . Am J Surg Pathol. 6:1982;93-108.
20. Martinez A., Podratz K., Schray M., et al. Results of whole abdominopelvic irradiation with nodal boost for patients with endometrial cancer at high risk of failure in the peritoneal cavity. Hematol Oncol Clin North Am. 2:1988;341-446.
21. Martinez A., Schray M., Podratz K., et al. Postoperative whole abdomino-pelvic irradiation for patients with high risk endometrial cancer. Int J Radiat Oncol Biol Phys. 17:1989;371-377.
22. Gibbons S., Martinez A., Schray M., et al. Adjuvant whole abdominopelvic irradiation for high risk endometrial carcinoma. Int J Radiat Oncol Biol Phys. 21:1991;1019-1025.
23. Miller K.T., Martinez A.A., Petersen I., et al. Long term outcome of adjuvant whole abdominopelvic radiation therapy for patients with high risk and papillary serous endometrial carcinoma. [Abstract] Presented at the 37th Annual Meeting of the American Society for Therapeutic Radiology and Oncology. 1995.
24. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
25. Gehan E. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika. 52:1965;203-223.
26. Marchetti D.L., Caglar H., Driscoll D.L., et al. Pelvic radiation in stage I endometrial adenocarcinoma with high-risk attributes. Gynecol Oncol. 37:1990;51-54.
27. Piver M.S., Hempling R.E. A prospective trial of postoperative vaginal radium/cesium for 1-2 less than 50% myometrial invasion and pelvic radiation for grade 3 or deep myometrial invasion in surgical stage I endometrial adenocarcinoma. Cancer. 66:1990;1133-1138.
28. Kadar N., Malfetano J.H., Homesley H.D. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus Implications for therapy . Obstet Gynecol. 80:1992;655-659.
29. Greer B.E., Hamberger A.D. Treatment of intraperitoneal metastatic adenocarcinoma of the endometrium by the whole-abdomen moving-strip technique and pelvic boost irradiation. Gynecol Oncol. 16:1983;365-373.
30. Loeffler J.S., Rosen E.M., Niloff J.M., et al. Whole abdominal irradiation for tumors of the uterine corpus. Cancer. 61:1988;1332-1335.
31. Mallipeddi P., Kapp D.S., Teng N.N.H. Long-term survival with adjuvant whole abdominopelvic irradiation for uterine papillary serous carcinoma. Cancer. 71:1993;3076-3081.
32. Potish R.A., Twiggs L.B., Adcock L.L., et al. Role of whole abdominal radiation therapy in the management of endometrial cancer Prognostic importance of factors indicating peritoneal metastases . Gynecol Oncol. 21:1985;80-86.
33. Small W., Mahadevan A., Roland P., et al. Whole-abdominal radiation in endometrial carcinoma An analysis of toxicity, patterns of recurrence, and survival . Cancer J. 6:2000;394-400.
34. Smith R.S., Kapp D.S., Chen Q., et al. Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy. Int J Radiat Oncol Biol Phys. 48:2000;767-778.
35. Morrow C.P., Bundy B.N., Homesley H.D., et al. Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II A Gynecology Oncology Group study . Gynecol Oncol. 36:1990;166-171.
36. Smith M.R., Peters W.A., Drescher C.W. Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma. Am J Obstet Gynecol. 170:1994;1677-1682.
37. Thigpen J.T., Blessing J.A., DiSaia P.J., et al. A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma A Gynecology Oncology Group study . J Clin Oncol. 12:1994;1408-1414.
38. Burke T.W., Gershenson D.M., Morris M., et al. Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in high-risk endometrial carcinoma. Gynecol Oncol. 55:1994;47-50.
39. Price F.V., Edwards R.P., Kelley J.L., et al. A trial of outpatient paclitaxel and carboplatin for advanced, recurrent, and histologic high-risk endometrial carcinoma Preliminary report . Semin Oncol. 24:(5 Suppl. 15):1997;78-82.
40. Zanotti K.M., Belinson J.L., Kennedy A.W., et al. The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma. Gynecol Oncol. 74:1999;272-277.
41. Creasman W.T., Morrow C.P., Bundy B.N., et al. Surgical pathologic spread patterns of endometrial cancer. Cancer. 60:(8 Suppl.):1987;2035-2041.
42. Schink J.C., Rademaker A.W., Miller D.S., et al. Tumor size in endometrial cancer. Cancer. 67:1991;2791-2794.
43. Sutton G.P., Brill L., Michael H., et al. Malignant papillary lesions of the endometrium. Gynecol Oncol. 27:1987;294-304.
44. O'Hanlan K.A., Levine P.A., Harbatkin D., et al. Virulence of papillary endometrial carcinoma. Gynecol Oncol. 37:1990;112-119.
45. Frick H.C., Munnell E.W., Richart R., et al. Carcinoma of the endometrium. Am J Obstet Gynecol. 115:1973;663-676.
46. Malkasian G.D., McDonald T.W., Pratt J.H. Carcinoma of the endometrium Mayo Clinic experience . Mayo Clin Proc. 52:1977;175-180.
47. Danoff B.F., McDay J., Louka M., et al. Stage III endometrial carcinoma Analysis of patterns of failure and therapeutic implications . Int J Radiat Oncol Biol Phys. 6:1980;1491-1495.
48. Aalders J.G., Syde R.V.D., Poppena S., et al. Prognostic factors and changing trends in the treatment of stage I endometrial cancer A clinical and histological study of 182 patients . Int J Radiat Oncol Biol Phys. 10:1984;2083-2099.
49. MacKillop W.J., Pringle J.F. Stage III endometrial carcinoma A review of 90 cases . Cancer. 56:1985;2519-2593.